Analysts set USD 1.50 target for Accendra Health stock

Published on 10/17/2026 at 20:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Accendra Health received six months to cure its October 6, 2026 NYSE notice. Accendra Health stock last stood at USD 0.23 on October 16, 2026.

Analyst target and listing status

Five analysts supported a USD 1.50 consensus target on October 5, 2026.
Accendra Health received six months to cure its NYSE listing deficiency after October 6, 2026.
Accendra Health stock was last at USD 0.23 on October 16, 2026 at 4:00 p.m. ET, down 10.13 percent on the NYSE versus the prior close.
Accendra Health's price-to-earnings ratio was -0.06 as of October 16, 2026.

ACH, US6907321029, Illustration mit AI erstellt.

Five analysts put Accendra Health's consensus target at USD 1.50 on October 5, 2026, according to MarketBeat. That target was 552.17 percent above the last NYSE price of USD 0.23. Accendra Health stock was last at USD 0.23 on October 16, 2026 at 4:00 p.m. ET, down 10.13 percent on the NYSE versus the prior close.

Market value and range

Accendra Health had a market capitalization of USD 18.1 million as of October 16, 2026. Its 52-week range was USD 0.22 to USD 5.60, placing the last price 4.55 percent above the low and 95.89 percent below the high.

The valuation data also show the strain in the equity story. The price-to-earnings ratio was -0.06 as of October 16, 2026, while the latest quoted volume was 2,943,939 shares against an average volume of 1,567,795 shares.

Listing compliance remains an issue

On October 6, 2026, Accendra Health received an NYSE notice because its average closing price had stayed below USD 1.00 for 30 consecutive trading days, according to the company's filing with the SEC. The company has six months to regain compliance, and the notice did not immediately remove the stock from the NYSE.

The filing says Accendra Health must notify the NYSE of its intention to cure the deficiency within 10 business days. A reverse stock split is among the alternatives mentioned in the related release, subject to shareholder approval if needed.

Comparison with peers

Accendra Health (NYSE, USD): minus 10.13 percent, P/E -0.06, market capitalization USD 18.1 million

Option Care Health (Nasdaq, USD): minus 0.06 percent, P/E 23.46, market capitalization USD 4.7 billion

Addus HomeCare (Nasdaq, USD): minus 0.44 percent, P/E 20.35, market capitalization USD 2.2 billion

Next reporting date

Zacks lists October 29, 2026 as the estimated date for Accendra Health's next earnings release. The page also lists a consensus estimate of a USD 0.05 loss per share for the quarter ending September 2026.

Price context

Accendra Health's last NYSE price of USD 0.23 on October 16, 2026 at 4:00 p.m. ET left the stock near its 52-week low of USD 0.22, with the market value at USD 18.1 million.